$NTLA
Intellia Therapeutics, Inc.

2018 Q3 Form 10-Q Financial Statement

#000156459018025733 Filed on October 31, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3 2016 Q4
Revenue $7.408M $7.317M $5.630M
YoY Change 1.24% 50.25% 233.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.270M $5.710M $5.120M
YoY Change 44.83% 21.23% 82.21%
% of Gross Profit
Research & Development $23.24M $17.48M $11.33M
YoY Change 32.93% 122.38% 158.99%
% of Gross Profit
Depreciation & Amortization $1.150M $790.0K $400.0K
YoY Change 45.57% 192.59% 207.69%
% of Gross Profit
Operating Expenses $23.24M $17.48M $11.33M
YoY Change 32.93% 122.38% 158.99%
Operating Profit -$24.10M -$15.88M -$10.82M
YoY Change 51.8% 106.25% 97.09%
Interest Expense $1.400M $520.0K $260.0K
YoY Change 169.23% 136.36%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$22.70M -$15.36M -$10.56M
YoY Change 47.79% 105.29% 92.37%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$22.70M -$15.36M -$10.56M
YoY Change 47.84% 105.24% 101.39%
Net Earnings / Revenue -306.45% -209.87% -187.62%
Basic Earnings Per Share
Diluted Earnings Per Share -$525.9K -$436.5K -$305.3K
COMMON SHARES
Basic Shares Outstanding 36.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q3 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $293.2M $222.3M $273.1M
YoY Change 31.89% -23.5% 260.29%
Cash & Equivalents $293.2M $222.3M $273.1M
Short-Term Investments
Other Short-Term Assets $2.800M $2.300M $1.800M
YoY Change 21.74% 130.0% 125.0%
Inventory
Prepaid Expenses
Receivables $2.813M $4.500M $6.454M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $298.8M $229.1M $281.3M
YoY Change 30.44% -21.73% 262.39%
LONG-TERM ASSETS
Property, Plant & Equipment $16.94M $13.60M $10.63M
YoY Change 24.52% 147.63% 292.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.469M $6.600M $7.035M
YoY Change -17.14% 101.53% 289.75%
Total Long-Term Assets $22.40M $20.10M $17.66M
YoY Change 11.46% 129.27% 291.38%
TOTAL ASSETS
Total Short-Term Assets $298.8M $229.1M $281.3M
Total Long-Term Assets $22.40M $20.10M $17.66M
Total Assets $321.2M $249.2M $299.0M
YoY Change 28.91% -17.34% 263.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.754M $2.200M $4.652M
YoY Change -20.27% 234.86% 242.06%
Accrued Expenses $9.893M $5.900M $5.900M
YoY Change 67.68% 22.66% 111.62%
Deferred Revenue $14.27M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.92M $25.80M $30.73M
YoY Change 0.45% 13.99% 187.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $52.00K $47.50M $293.0K
YoY Change -99.89% 15422.88% -9.29%
Total Long-Term Liabilities $52.00K $47.50M $293.0K
YoY Change -99.89% 15422.88% -9.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.92M $25.80M $30.73M
Total Long-Term Liabilities $52.00K $47.50M $293.0K
Total Liabilities $25.97M $73.30M $31.02M
YoY Change -64.57% 219.54% 181.57%
SHAREHOLDERS EQUITY
Retained Earnings -$182.0M -$53.57M
YoY Change 144.21%
Common Stock $445.2M $263.4M
YoY Change 35737.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $263.3M $175.8M $209.8M
YoY Change
Total Liabilities & Shareholders Equity $321.2M $249.2M $299.0M
YoY Change 28.91% -17.34% 263.98%

Cashflow Statement

Concept 2018 Q3 2017 Q3 2016 Q4
OPERATING ACTIVITIES
Net Income -$22.70M -$15.36M -$10.56M
YoY Change 47.84% 105.24% 101.39%
Depreciation, Depletion And Amortization $1.150M $790.0K $400.0K
YoY Change 45.57% 192.59% 207.69%
Cash From Operating Activities -$12.45M -$16.89M -$14.41M
YoY Change -26.29% 121.94% 162.48%
INVESTING ACTIVITIES
Capital Expenditures -$2.020M -$2.260M -$3.410M
YoY Change -10.62% 276.67% 305.95%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.020M -$2.260M -$3.410M
YoY Change -10.62% 276.67% 305.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.180M 370.0K 260.0K
YoY Change 489.19% -119.89% -157.78%
NET CHANGE
Cash From Operating Activities -12.45M -16.89M -14.41M
Cash From Investing Activities -2.020M -2.260M -3.410M
Cash From Financing Activities 2.180M 370.0K 260.0K
Net Change In Cash -12.29M -18.78M -17.56M
YoY Change -34.56% 86.49% 159.0%
FREE CASH FLOW
Cash From Operating Activities -$12.45M -$16.89M -$14.41M
Capital Expenditures -$2.020M -$2.260M -$3.410M
Free Cash Flow -$10.43M -$14.63M -$11.00M
YoY Change -28.71% 108.7% 136.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2813000
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2768000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
298829000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16935000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5469000
CY2018Q3 us-gaap Assets
Assets
321233000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1754000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23237000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17481000
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
31507000
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
23192000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24099000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15875000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9893000
CY2018Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14268000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21188000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
25915000
CY2018Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
31996000
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
44111000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-22702000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-15356000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35189000
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1397000
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
519000
us-gaap Costs And Expenses
CostsAndExpenses
64289000
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
445225000
us-gaap Operating Income Loss
OperatingIncomeLoss
-70124000
us-gaap Operating Income Loss
OperatingIncomeLoss
-44840000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3847000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1260000
us-gaap Net Income Loss
NetIncomeLoss
-66277000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-181959000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
263270000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
321233000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43369323
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43369323
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7408000
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7317000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22554000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19449000
CY2017Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseAndServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseAndServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseAndServiceMember
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23481000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17812000
us-gaap Costs And Expenses
CostsAndExpenses
92678000
us-gaap Net Income Loss
NetIncomeLoss
-43580000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.55
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.25
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43161000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
42684000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34945000
us-gaap Profit Loss
ProfitLoss
-66277000
us-gaap Profit Loss
ProfitLoss
-43580000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3237000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2161000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
16000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-112000
us-gaap Share Based Compensation
ShareBasedCompensation
13464000
us-gaap Share Based Compensation
ShareBasedCompensation
8726000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7658000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1961000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-913000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
508000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-65000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-232000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1423000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
302000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13604000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-13298000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-664000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-478000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5119000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4456000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
21.29
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.028
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.877
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-116000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-92000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52719000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43970000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4766000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7694000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4766000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7694000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9457000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
508000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
598000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
356000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10055000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
864000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-47430000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-50800000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
273064000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
222264000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
922000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
601000
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
59868000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
3000000
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-16604000
CY2018Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
46264000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16604000
CY2018Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseAndServiceMember
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2018Q3 us-gaap Capitalized Contract Cost Gross
CapitalizedContractCostGross
0
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4773000
CY2018Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4774000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3226000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3247000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13464000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8726000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
479822
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
86250
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
378033
ntla Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriod
44524
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
143515
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
22.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.79
ntla Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Cancelled In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledInPeriodWeightedAverageGrantDateFairValue
8.48
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.13
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
2200000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.19
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.73
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.026
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.954
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.889
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.930
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4705448
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1076731
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
982142
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
547529
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4252508
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1616167
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.09
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
24.43
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.63
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
16.55
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.20
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.49
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M29D
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
57432000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
29419000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
30100000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4397000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5187000

Files In Submission

Name View Source Status
0001564590-18-025733-index-headers.html Edgar Link pending
0001564590-18-025733-index.html Edgar Link pending
0001564590-18-025733.txt Edgar Link pending
0001564590-18-025733-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ntla-10q_20180930.htm Edgar Link pending
ntla-20180930.xml Edgar Link completed
ntla-20180930.xsd Edgar Link pending
ntla-20180930_cal.xml Edgar Link unprocessable
ntla-20180930_def.xml Edgar Link unprocessable
ntla-20180930_lab.xml Edgar Link unprocessable
ntla-20180930_pre.xml Edgar Link unprocessable
ntla-ex101_327.htm Edgar Link pending
ntla-ex311_8.htm Edgar Link pending
ntla-ex312_9.htm Edgar Link pending
ntla-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending